SearchResearch
Beta
Hello! Describe your research question and I'll help you find matching datasets across 2,944 studies from AnVIL, BDC, CRDC, and KFDRC.

Genome Wide Association Studies in ECOG 2997 Trial

Request Access

Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997.

I. Flinn, D. Neuberg, M. Grever, et al. (2007). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 384 times. https://doi.org/10.1200/JCO.2006.08.0762

Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997.

M. Grever, D. Lucas, G. Dewald, et al. (2007). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 366 times. https://doi.org/10.1200/JCO.2006.08.3089

Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes

M. Larson, Larry D. Atwood, Emelia J. Benjamin, et al. (2007). BMC Medical Genetics. Cited 200 times. https://doi.org/10.1186/1471-2350-8-S1-S5

Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.

Mitchell R. Smith, D. Neuberg, I. Flinn, et al. (2011). Blood. Cited 44 times. https://doi.org/10.1182/blood-2011-03-342485

Oral Contraceptive Hypertension and Thromboembolism

W. Kannel. (1979). International Journal of Gynecology & Obstetrics. Cited 22 times. https://doi.org/10.1002/j.1879-3479.1979.tb00951.x